Results 1 to 10 of about 170,853 (120)

Immunoradiometric assay of CA 125 in effusions comparison with carcinoembryonic antigen [PDF]

Cancer, 1987
The levels of CA 125 antigen were measured in 167 effusions from 150 patients using radioimmunoassay, and the results compared with the levels of carcinoembryonic antigen (CEA) in the fluids. This study was carried out to test a hypothesis that measuring the combined levels of selected tumor associated antigens in effusions could predict the primary ...
M M, Pinto, L H, Bernstein, D A, Brogan, E, Criscuolo   +3 more
openaire   +2 more sources

Comparison of seven immunoassays for the quantification of CA 125 antigen in serum [PDF]

Clinical Chemistry, 1998
Abstract Seven CA 125 immunoassays were compared for their clinical performance. CA 125 concentrations were determined in 289 serum samples obtained from women with benign pelvic tumors (samples from 98 patients) and patients with various cancers (samples from 111 patients).
E M, Davelaar, G J, van Kamp, R A, Verstraeten, P, Kenemans   +3 more
openaire   +2 more sources

Clinical Applicability of Tissue Polypeptide Antigen and CA-125 in Gynecological Malignancies

Biomedicines, 2023
Background: Nowadays there still is no sufficient screening tool for ovarian and uterine cancer. Objective: The current study aimed to investigate whether cancer antigen 125 (CA-125), tissue polypeptide antigen (TPA) or the combination of both markers are able to act as screening tools for ovarian or uterine cancer.
Lars Schröder, Christian M. Domroese, Alexander B. A. Rupp, Kathrin M. E. Gihr, Christoph Niederau, Michael R. Mallmann, Stefan Holdenrieder   +6 more
openaire   +3 more sources

Tumour Associated Antigens CA 15.3 and CA 125 in Ovarian Cancer

The International Journal of Biological Markers, 1991
CA 125 and CA 15.3 antigens were determined by enzyme immunoassay in 78 patients with ovarian cancer for a total of 540 determinations. The antigens were also investigated in sera from 100 women with other gynaecological diseases, 82 lung cancer patients and in 39 pleural fluids of varying origin.
Lotzniker M, Pavesi F, Scarabelli M, Vadacca G, FRANCHI, Massimo Piergiuseppe, Moratti R.   +5 more
openaire   +3 more sources

Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.

Clinical Chemistry, 1988
Abstract We found that ovarian cyst fluids contained carcinoembryonic antigen (CEA) and CA 19-9 and CA 125 tumor markers. However, only the ratio of CA 125 to CEA concentrations provided sufficient specificity to differentiate serous from mucinous cysts. For CEA measurement, our results suggested the use of a monoclonal CEA kit. When CEA
J T, Wu, T, Miya, J A, Knight, D P, Knight   +3 more
openaire   +2 more sources

[Cancer antigen CA 125 in ovarian cancer].

Ginekologia polska, 2004
To estimate the diagnostic and prognostic value, pathological and clinical correlation of cancer antigen 125 (CA125) in ovarian cancer (OC). Retrospective analysis was done of 350 patients who were operated for OC in years 1990-2001 in Gynecology Clinic MU of Gdansk. We analyzed those before primary operation (PO) and second look laparotomy (SLL).
Jarosław, Debniak, Maciej, Stukan, Małgorzata, Pietrzak-Stukan, Dagmara, Klasa-Mazurkiewicz   +3 more
openaire   +1 more source

Expression of CEA, CA-125 and SCC antigen by biological fluids associated with pregnancy

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1992
Carcinoembryonic antigen (CEA), cancer antigen 125 (CA-125) and squamous cell carcinoma (SCC) antigen were measured in 56 full-termed pregnancies by enzyme-immunoassays (EIA-MEIA). The measurements were done in maternal serum (MS), umbilical cord blood (UCB) and amniotic fluid (AF) samples, during delivery.
SARANDAKOU, A, KONTORAVDIS, A, KONTOGEORGI, Z, RIZOS, D, PHOCAS, I   +4 more
openaire   +3 more sources

[CA-125 antigen].

Postepy higieny i medycyny doswiadczalnej, 2002
This review describes the physicochemical and biological properties of antigen CA125 and clinical utility of antigen in oncologic diagnostic. CA125 is the most reliable marker for ovarian cancer in clinical practice. Analysis of CA125 values performed by many authors revealed its highest concentrations in serous and endrometrioid histological type ...
openaire   +1 more source

[CA-125 antigen in patients with cancer of the uterine body].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1991
In 72 patients with malignant neoplasms of uterine body the serum concentration was determined of CA 125 antigen. In 38 cases serum samples were taken before oncological treatment and in 34 cases after the first stage of treatment. It was found that CA 125 concentration was significantly higher in patients before the treatment, with higher values in ...
M, Gisterek, M, Wawrzkiewicz, J, Kornafel   +2 more
openaire   +1 more source

Purification and Characterization of the CA 125 Tumor-Associated Antigen from Human Ascites

Tumor Biology, 1993
CA 125 is an antigenic determinant associated with epithelial ovarian carcinomas, which is recognized by a monoclonal antibody, OC 125. The biochemical structure, the immunological characteristics and the physiological function of CA 125 are unknown, principally because the molecule expressing it has not been purified to homogeneity.
M T, de los Frailes, S, Stark, W, Jaeger, A, Hoerauf, L, Wildt   +4 more
openaire   +2 more sources